for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Shanghai Junshi Biosciences Sees Q1 Operating Income Between Rmb150 Mln To Rmb200 Mln

March 19 (Reuters) - Shanghai Junshi Biosciences Co Ltd :

* SEES Q1 OPERATING INCOME BETWEEN RMB150 MILLION TO RMB200 MILLION

* SEES QTRLY NET LOSS ATTRIBUTABLE BETWEEN RMB233.1 MILLION AND RMB198.5 MILLION

* COMPANY EXPECTS TO RECORD A RELATIVELY LARGER GROWTH IN Q1 OF 2020 AS COMPARED WITH Q1 OF 2019 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up